INTERNATIONAL PATENT: AXSOME THERAPEUTICS, INC. FILES APPLICATION FOR "USE OF REBOXETINE TO TREAT NARCOLEPSY"

GENEVA, Oct. 6 -- AXSOME THERAPEUTICS, INC. (One World Trade Center, 22nd FloorNew York, New York 10007) filed a patent application (PCT/US2025/021386) for "USE OF REBOXETINE TO TREAT NARCOLEPSY" on Mar 25, 2025. With publication no. WO/2025/207664, the details related to the patent application was published on Oct 02, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): TABUTEAU, Herriot (One World Trade Center, 22nd FloorNew York, New York 10007)

Abstract: Polymorph forms of reboxetine, and their therapeutic uses, are described herein. Also described herein are methods of treating narcolepsy w...